Title : Semaglutide May Alleviate Hepatic Steatosis in T2DM Combined with NFALD Mice via miR-5120\/ABHD6 - Li_2022_Drug.Des.Devel.Ther_16_3557 |
Author(s) : Li R , Ye Z , She D , Fang P , Zong G , Hu K , Kong D , Xu W , Li L , Zhou Y , Zhang K , Xue Y |
Ref : Drug Des Devel Ther , 16 :3557 , 2022 |
Abstract : Li_2022_Drug.Des.Devel.Ther_16_3557 |
ESTHER : Li_2022_Drug.Des.Devel.Ther_16_3557 |
PubMedSearch : Li_2022_Drug.Des.Devel.Ther_16_3557 |
PubMedID: 36238196 |
Li R, Ye Z, She D, Fang P, Zong G, Hu K, Kong D, Xu W, Li L, Zhou Y, Zhang K, Xue Y (2022)
Semaglutide May Alleviate Hepatic Steatosis in T2DM Combined with NFALD Mice via miR-5120\/ABHD6
Drug Des Devel Ther
16 :3557
Li R, Ye Z, She D, Fang P, Zong G, Hu K, Kong D, Xu W, Li L, Zhou Y, Zhang K, Xue Y (2022)
Drug Des Devel Ther
16 :3557